HHT: Vascular Biology and Pathophysiology Workshop Agenda

Home

About

Reports and Publications

Reports and Workshop Summaries from OD

Hereditary Hemorrhagic Telangiectasia: Vascular Biology and Pathophysiology

Agenda

#dynamic_l {list-style:none; margin:0; padding:5px; line-height:110%;} #dynamic_l ul {list-style:none;; margin:0; padding:0; line-height:100%} #dynamic_l li {border-bottom:1px solid #dcdcdc; padding:5px} #dynamic_l li li {border-bottom:0} /*#dynamic_l ul {list-style:none; margin:0; padding:0;}*/ /*#dynamic_l ul a {font-size:86%; text-decoration:none; color:#069}*/ #dynamic_l a {font-size:90%; text-decoration:none; color:#000; font-family:Tahoma, Geneva, sans-serif} #dynamic_l a:hover {text-decoration:underline}

Hereditary Hemorrhagic Telangiectasia: Vascular Biology and Pathophysiology

Hereditary Hemorrhagic Telangiectasia: Vascular Biology
and Pathophysiology

Agenda

Wednesday, June 7, 2006
1:00 p.m.	Optional Grant Writing / Training and Career Opportunities Workshop
Thursday, July 8, 2003
8:00 a.m.	Welcome: Francis Collins, Charles Peterson, Stephen Groft, Marianne Clancy
8:20 a.m.	Keynote I: Overview of Transforming Growth Factor- β Pathway - Jeff Wrana
8:50 a.m.	Keynote II: Transforming Growth Factor- β Pathway and HHT - Carmelo Bernabeu
9:10 a.m	Platform Presentations: Transforming Growth Factor- β Pathway Identification and Characterization of Genetic Loci that Determine Mouse Strain-Specific Requirements for Tgfb1 during Developmental Angiogenesis - Rosemary Akhurst BMP9 Is a Potent Activator of ALK1 Signalling in Endothelial Cells - Sabine Bailly Smad-Independent Roles for Endoglin in Vascular Cell Function - Calvin Vary
10:15 a.m.	Discussion: Transforming Growth Factor- β Pathway
10:45 a.m	Keynote III: Overview of Vascular Biology - Marlene Rabinovitch
11:15 a.m.	Keynote IV: Vascular Biology and HHT - Michelle Letarte
11:45 a.m.	Platform Presentations: Vascular Biology Alk1 Activation Favors Resolution in the Zebrafish Endothelium - Beth Roman Endoglin Has a Crucial Role in Blood Cell-Mediated Vascular Repair - Linda van Laake
12:15 p.m.	Discussion: Vascular Biology
1:30 p.m.	Keynote V: Overview of Endothelial Biology - Luisa Iruela-Arispe
2:00 p.m.	Keynote VI: Endothelial Biology and HHT - Duncan Stewart
2:30 p.m.	Platform Presentations: Endothelial Biology Contribution of Endothelial O-Glycans to Vascular Development - Lijun Xia The Characterization of Endothelial Cells from Hereditary Haemorrhagic Telangiectasia Patients Reveals Abnormalities in Cytoskeleton and Tube Formation - Africa Fernandez-Lopez
3:00 p.m.	Discussion: Endothelial Biology
3:30 p.m.	Keynote VII: Overview of Chemical Genomics - Christopher Austin
4:00 p.m.	Discussion: Chemical Genomics and HHT
4:30 p.m.	Poster Session I (odd-numbered posters)
5:30 p.m.	Poster Session II (even-numbered posters)
Friday, June 9, 2006
7:00 a.m.	Poster Viewing
8:00 a.m.	Keynote VIII: Animal Models of Vascular Pathophysiology - Dean Li
8:30 a.m.	Keynote IX: HHT Organ Pathophysiology in Humans - Marie Faughnan
9:00 a.m.	Platform Presentations: Organ Pathophysiology In Vivo Assessment of the ALK1-ALK5 Balance for Mediating TGF-β Signal in Endothelium during Vascular Development in Mice - Paul Oh Abnormal Development of Retinal Vasculature and Retinal Neovascularization during Oxygen-Induced Ischemic Retinopathy in Endoglin Heterozygous Mice - Nader Sheibani
9:45 a.m.	Discussion: Organ Pathophysiology
10:50 a.m.	Concurrent Workshops Transforming Growth Factor- β Pathway Vascular Biology Endothelial Biology Organ Pathophysiology
1:45 p.m.	Workshop Reports and Discussions
3:45 p.m.	Summary and Future Directions

All presentation slides are in format. To view, download the free Adobe Reader.

Top of page

Last Reviewed: December 25, 2012